论文部分内容阅读
目的观察普米克令舒联合博力康尼雾化吸入治疗哮喘急性发作的疗效。方法将120例哮喘急性发作期患者随机分成两组,两组均采用综合治疗(抗炎、化痰、平喘、吸氧)。治疗组加用普米克令舒和博力康尼联合溶液雾化吸入,观察治疗后患者病情转归及肺功能的改善情况。结果治疗组与对照组总有效率分别为93.3%、66.7%,治疗组明显优于对照组,差异有统计学意义(P<0.05)。结论在常规治疗基础上加用普米克令舒博力康尼联合溶液雾化吸入治疗哮喘急性发作,可缩短病程,疗效确切,且方便、安全,值得临床推广。
Objective To observe the curative effect of Pulmicort Respules with Boli Kang Nebulization in the treatment of acute asthma attack. Methods A total of 120 patients with acute exacerbation of asthma were randomly divided into two groups. The two groups were treated with combined therapy (anti-inflammatory, phlegm, asthma, and oxygen). The treatment group plus Pulmicort respules with Boli Kang joint solution atomized inhalation, observation of patients after treatment and prognosis of patients with lung function improvement. Results The total effective rates of the treatment group and the control group were 93.3% and 66.7%, respectively, which were significantly better in the treatment group than those in the control group (P <0.05). Conclusions The routine treatment based on the combination of Pulmicort respucation with Concomitant solution inhalation treatment of acute asthma attack, can shorten the course of the disease, the curative effect is exact, and convenient and safe, worthy of clinical promotion.